Projection of cancer incidence is essential for planning cancer control actions, health care
and allocation of resources. Here we project the cancer burden at the National and State …

The Indian government suspended research in April 2010 on the feasibility and safety of
human papillomavirus (HPV) vaccine in two Indian states (Andhra Pradesh and Gujarat) …

Gynaecologic cancers contribute significantly to the cancer burden in developing countries,
resulting in higher mortality and morbidity rates among women in these nations. This …

Cancer besides being a leading cause of mortality also creates a myriad of morbidities in
survivors whether treated or untreated. Among women surviving after gynecological …

The incidence and mortality of cervical cancer remains high in India even after sixty years of
introduction of the Pap smear (cervical cytology) which is an effective means of identifying …

Background: In an effort to decrease the toll of cervical cancer, by its knowledge, prevention
and treatment services in the community, we provided a nuanced consideration of the …

The major capsid protein (L1) of human papillomaviruses (HPV) expressed in heterologous
systems assembles into virus-like particles (VLPs). We report cloning and expression of …

To achieve maximum efficacy, vaccines, such as subunit, recombinant, and conjugate
vaccines, necessitate the incorporation of immunostimulators/adjuvants. Adjuvants play a …

Purpose A demonstration project was conducted to assess feasibility of implementing HPV
detection-based cervical cancer screening in primary care settings in India and to generate …

Cervical cancer is one of the leading causes of morbidity and mortality among women but
can be prevented through simple cost‐effective measures, such as creating awareness, and …